Sequence types 235, 111, and 132 Predominate among multidrug-resistant Pseudomonas aeruginosa clinical isolates in croatia

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 10, 2014, Pages 6277-6283

  Guzvinec, Marija ^a   Izdebski, Radostaw ^b   Butic, Iva ^a   Jelic, Marko ^a   Abram, Maja ^c   Koscak, Iva ^d   Baraniak, Anna ^b   Hryniewicz, Waleria ^b   Gniadkowski, Marek ^b   Andrasevic, Arjana Tambic ^a  

^a Croatia   (Croatia)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c KBC RIJEKA   (Croatia)

^d Institute for Public Health   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; CLAVULANIC ACID; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; METALLO BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLONE; CROATIA; HUMAN; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; SEROTYPE; DRUG EFFECTS; ENZYMOLOGY; GENETICS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINASE; CROATIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; PSEUDOMONAS AERUGINOSA;

EID: 84907279956     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03116-14     Document Type: Article

References (40)

1. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. http://dx.doi.org/10.3389/fmicb.2011.00065.
2. Livermore DM. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640. http://dx.doi.org/10.1086/338782.
3. Cholley P, Thouverez M, Hocquet D, Mee-Marquet N, Talon D, Bertrand X. 2011. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J. Clin. Microbiol. 49:2578-2583. http://dx.doi.org/10.1128/JCM.00102-11.
4. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610. http://dx.doi.org/10.1128/CMR.00040-09.
5. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
6. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-ß-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325. http://dx.doi.org/10.1128/CMR.18.2.306-325.2005.
7. Weidhagen GF, Poirel L, Nordmann P. 2003. Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392. http: //dx.doi.org/10.1128/AAC.47.8.2385-2392.2003.
8. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649. http://dx.doi.org/10.1128/JCM.42.12.5644-5649.2004.
9. Giske CG, Libisch B, Colinon C, Scoulica E, Pagani L, Fuzi M, Kronvall G, Rossolini GM. 2006. Establishing clonal relationships between VIM-1-like metallo-ß-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J. Clin. Microbiol. 44:4309-4315. http://dx.doi.org/10.1128/JCM.00817-06.
10. Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, Lanotte P, Mastouri M, Elghmati MS, Rojo F, Mejdi S, Giske CG. 2011. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617. http://dx.doi.org/10.1371/journal.pone .0025617.
11. Nemec A, Krizova L, Maixnerova M, Musilek M. 2010. Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Res. Microbiol. 161:234-242. http://dx. doi.org/10.1016/j.resmic.2010.02.002.
12. Empel J, Filczak K, Mrowka A, Hryniewicz W, Livermore DM, Gniad-kowski M. 2007. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum β-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J. Clin. Microbiol. 45:2829-2834. http://dx.doi.org/10.1128/JCM.00997-07.
13. Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, Chaves F, Oliver A. 2009. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum ß-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 53:4930-4933. http://dx.doi.org/10.1128/AAC.00900-09.
14. Edelstein MV, Skleenova EN, Shevchenko OV, D'Souza JW, Tapalski DV, Azizov IS, Sukhorukova MV, Pavlukov RA, Kozlov RS, Toleman MA, Walsh TR. 2013. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a lon-gitudinal epidemiological and clinical study. Lancet Infect. Dis. 13:867-876. http://dx.doi.org/10.1010/S1473-3099 (13)70168-3.
15. Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, Szabó G, Füzi M. 2008. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res. Microbiol. 159:162-168. http: //dx.doi.org/10.1016/j.resmic.2007.12.008.
16. Tambic Andrasevic A, Tambic T, Kalenic S, Jankovic V. 2002. Surveillance for antimicrobial resistance in Croatia. Emerg. Infect. Dis. 8:14-18. http://dx.doi.org/10.3201/eid0801.010143.
17. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and inter-laboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43: 4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335.2005.
19. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
20. García-Castillo M, Del Campo R, Morosini MI, Riera E, Cabot G, Willems R, van Mansfeld R, Oliver A, Cantón R. 2011. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J. Clin. Microbiol. 49:2905-2910. http://dx.doi.org/10.1128/JCM .00753-11.
21. Cabot G, Ocampo-Sosa AA, Domínguez MA, Gago JF, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martinez-Martinez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI). 2012. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob. Agents Chemother. 56:6349-6357. http://dx.doi.org/10.1128/AAC.01388-12.
22. Sardelic S, Bedenic B, Colinon-Dupuich C, Orhanovic S, Bosnjak Z, Plecko V, Cournoyer B, Rossolini GM. 2012. Infrequent finding of metallo-ß-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob. Agents Chemother. 56: 2746-2749. http://dx.doi.org/10.1128/AAC.05212-11.
23. Kim MJ, Bae IK, Jeong SH, Kim SH, Song JH, Choi JY, Yoon SS, Thamlikitkul V, Hsueh P-R, Yasin RM, Lalitha MK, Lee K. 2013. Dissemination of metallo-ß-lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries. J. Antimicrob. Chemother. 68:2820-2824. http://dx.doi.org/10.1093/jac/dkt269.
24. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier J-D, Rossolini GM. 2013. FIM-1, a new acquired metallo-ß-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57:410-416. http://dx.doi.org/10.1128/AAC.01953-12.
25. Janvier F, Jeannot K, Tessé S, Robert-Nicoud M, Delacour H, Rapp C, Mérens A. 2013. Molecular characterization of in a sequence type 235 Pseudomonas aeruginosa isolate from France. Antimicrob. Agents Chemother. 57:3408-3411. http://dx.doi.org/10.1128/AAC .02334-12.
26. Edalucci E, Spinelli R, Dolzani L, Riccio ML, Dubois V, Tonin EA, Rossolini GM, Lagatolla C. 2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 14:88-90. http://dx.doi.org/10.1111/j .1469-0691.2007.01874.x.
27. Van der Bij AK, Van der Zwan D, Peirano G, Severin JA, Pitout JDD, Van Westreenen M, Goessens WHF. 2012. Metallo-ß-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin. Microbiol. Infect. 18:E369-E372. http://dx.doi.org/10.1111/j.1469-0691.2012.03969.x.
28. Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodriguez C, Moya B, Zamorano L, Suarez C, Pena C, Martinez-Martinez L, Oliver A. 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55:1906-1911. http://dx.doi.org/10.1128/AAC.01645-10.
29. Lee K, Lim YS, Yong D, Yum JH, Chong Y. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-ß-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629. http://dx.doi.org /10.1128/JCM.41.10.4623-4629.2003.
30. Fiett J, Baraniak A, Mrowka A, Fleischer M, Drulis-Kawa Z, Naumiuk L, Samet A, Hryniewicz W, Gniadkowski M. 2006. Molecular epidemiology of acquired-metallo-ß-lactamase-producing bacteria in Poland. Antimicrob. Agents Chemother. 50:880-886. http://dx.doi.org/10.1128 /AAC.50.3.880-886.2006.
31. Poirel L, Cabanne L, Vahaboglu H, Nordmann P. 2005. Genetic environment and expression of the extended- spectrum beta-lactamase blaPER-1 gene in Gram-negative bacteria. Antimicrob. Agents Chemother. 49: 1708-1713. http://dx.doi.org/10.1328/AAC49.5.1708-1713.2005.
32. Tato M, Coque TM, Baquero F, Canton R. 2010. Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 54:320-327. http: //dx.doi.org/10.1128/AAC.00783-09.
33. Vourli S, Tzouvelekis LS, Tzelepi E, Lebessi E, Legakis NJ, Miriagou V. 2003. Characterization of In111, a class 1 integron that carries the extended-spectrum ß-lactamase gene blaIBC-1. FEMS Microbiol. Lett. 225:149-153. http://dx.doi.org/10.1016/S0378-1097(03)00510-X.
34. Libisch B, Poirel L, Lepsanovic Z, Mirovic V, Balogh B, Pászti J, Hunyadi Z, Dobák A, Füzi M, Nordmann P. 2008. Identification of PER-1 extended-spectrum β-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol. Med. Microbiol. 54:330-338. http://dx. doi.org/10.1111/j. 1574-695X.2008.00483.X.
35. Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Serai C, Castillo FJ, Torres C, Sáenz Y. 2014. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallobeta-lactamases, porin OprD and integrons. Int. J. Med. Microbiol. 304: 405-414. http://dx.doi.org/10.1016/j.ijmm.2034.01.001.
36. Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, Perilli M, Pollini S, Spalla M, Amicosante G, Toniolo A, Pagani L. 2008. First countrywide survey of acquired metallo-ß-lactamases in Gram-negative pathogens in Italy. Antimicrob. Agents Chemother. 52: 4023-4029. http://dx.doi.org/10.1128/AAC.00707-08.
37. Juan C, Beceiro A, Gutiérrez O, Alberti S, Garau M, Pérez JL, Bou G, Oliver A. 2008. Characterization of the new metallo-ß-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob. Agents Chemother. 52:3589-3596. http://dx. doi.org/10.1128/AAC.00465-08.
38. Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson M-O, Couetdic G, Plésiat P. 2007. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother. 51:3531-3536. http://dx.doi.org/10.1128/AAC.00503-07.
39. Gutierrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Perez JL, Oliver A. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335. http://dx.doi.org/10.1128/AAC.00810-07.
40. Akasaka T, Tanaka M, Yamaguchi A, Sato K. 2001. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob. Agents Chemother. 45: 2263-2268. http://dx.doi.org/10.1128/AAC.45.8.2263-2268.2001.